IP Library Assignment 026246/0796
Patent Assignment
Reel/Frame 026246/0796

Assignment of Assignor's Interest

Recorded: 2011-05-09 Pages: 19
Assignor
GENAERA LIQUIDATING TRUST
Executed: 2009-08-21
Assignee
OHR PHARMACEUTICAL, INC.
489 5TH AVENUE, 28TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Property (1)
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 7,981,876 →
Application: 11/410,098 →
Publication: US 2007/0010504
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2006
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 018283/0136 →
Liquidating Trust Agreement Mar 16, 2012
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 027874/0365 →
Certificate of Change of the Company's Address Mar 22, 2016
From: OHR PHARMACEUTICAL, INC.
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 038215/0748 →
Assignment of Assignor's Interest May 10, 2018
From: OHR PHARMACEUTICAL, INC.
To: ENTERIN, INC.
Reel/Frame 045764/0322 →